"Using Affimer technology, the data generated has been remarkable. My interest lies in blood clot formation, with the long-term aim of reducing heart attacks and strokes in high risk patients. A number of Affimer candidates have shown significant effects on the clotting process, which will help to develop novel therapeutic targets aiming to reduce thrombosis risk."
DR RAMZI AJJAN
ASSOCIATE PROFESSOR / CONSULTANT
UNIVERSITY OF LEEDS AND LEEDS NHS TRUST